The 4th Annual Digi-Tech Pharma & AI virtual brings with it even more interactive sessions, expert speakers, senior professionals and decision makers from leading pharma, bio-tech and healthcare industry. Meet the decision makers, benchmark and learn from real-life use cases to drive organizational change and to understand the new cutting-edge technologies and practical solutions. In this 4th edition as we explore the novel technologies and developments reforming pharmaceutical industry, we also dive deep into the implementation and advances in machine learning, deep learning, artificial intelligence, informatics and data science which has redefined the development of new drugs, tackle diseases, improving healthcare and much more.
The enhancements in data management and data integration are providing improvements to both the speed and quality of drug discovery and many clinical trial processes. To be in the forefront, a necessity for partnership and collaboration with healthcare provider is a must for the pharmaceutical companies, and these partnerships will also lead to massive advances in R&D using artificial intelligence in genomics and precision medicine to develop a deep understanding of the root causes of diseases.
The combination of AI, big data and IoT technologies are creating new innovations, also other eminent technologies like cloud computing, augmented reality, virtual reality and blockchain are being used extensively in the Pharmaceutical industry’s digital transformation.
It gives us a great pleasure to welcoming you to this international pharmaceutical technology virtual 4th Annual Digi-Tech Pharma & AI 2021.
Reimagining Pharma by Integrating Science and Technology:
Digital Discovery and Clinical Trials:
Decoding the Value of Data Science, Big Data & Informatics:
Real-World Data & Real-World Evidence:
Digital Health & Future Innovations:
This event is designed for senior level attendees from various companies including pharmaceutical, biotechnological, biopharmaceutical, CRO’s, Diagnostics, solution provider and government institutions.
Attendees includes Chief Data Officer, VPs, GMs, Directors, Heads and Managers of